Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Cymeed who wrote (587)	12/19/1997 9:06:00 AM
From: F. Jay Abella, III	Read Replies (1) \| Respond to of 887

Hi All: Please excuse the intrusion, but FWIW, I empathize entirely with the last two sentiments expressed here. As an analyst, I try not to go near companies whose fates are determined by binary outcomes like FDA advisory committees. Too much risk for me. I realize that what happened in DEPO/CHIR happens ALL THE TIME in biotech (how many times this month?). Really makes you wonder whether any of these companies can ever be viable. All the work, time and money and you still get nothing at the end of the day. Who wants to ever see another one of these things? The entire industry suffers when events like that which happened to DEPO occur. FJA